Gabapentinoids associated with increased risk of suicidal behaviourBMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l4208 (Published 13 June 2019) Cite this as: BMJ 2019;365:l4208
- Elisabeth Mahase
- The BMJ
Gabapentinoids—a group of drugs used to treat epilepsy, nerve pain, and anxiety disorders—are associated with an increased risk of suicidal behaviour, unintentional overdose, injuries, and road traffic incidents, new research published in The BMJ has found.1
Researchers looked at the associations between gabapentinoids and adverse outcomes related to coordination disturbances, mental health, and criminality, and found the risks were strongest among 15 to 24 year olds.
The study authors called for the guidance around prescribing of these drugs to younger …